WhiteOak Capital Mutual Fund Jumps into Sectoral Play with Pharma & Banking NFOs

WhiteOak Capital Mutual Fund has launched – WhiteOak Capital Banking & Financial Services Fund and WhiteOak Capital Pharma & Healthcare Fund.  

Both the funds are open-ended equity schemes investing in Banking & Financial services sector and in Pharma & Healthcare sector, respectively.

Accordingly, the primary objective of these Schemes is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma & Healthcare companies and in equity and equity related instruments of banks & companies engaged in Financial Services Sector.

However, there can be no assurance that the investment objective of these Schemes will be realized.

[Read: Mutual Funds Are Betting Big on These Sectors: Are You Missing Out?]

Under normal circumstances, WhiteOak Capital Banking & Financial Services Fund will hold an allocation of 80% to 100% in equity and equity related instruments of Banks & companies engaged in financial services sector. Whereas WhiteOak Capital Pharma & Healthcare Fund will hold an allocation of 80% to 100% in equity and equity related instruments of Pharma and Healthcare companies.

Both the schemes will hold 0% to 20% in Equity & Equity related Instruments companies other than above, 0% to 20% in Debt securities and money market instruments and 0% to 10% in Units issued by REITs & InvITs.

As per the Scheme Information Document, WhiteOak Capital Banking & Financial Services Fund will invest minimum 80% of its net assets in equity and equity related instruments of Banks & companies engaged in Financial Services Sector. Further, in order to achieve diversification in the Scheme will invest up to 20% of its net assets in companies other than those engaged in Financial Services Sector.

The Scheme will follow a bottom-up approach to stock-picking and choose companies which are expected to get benefitted from the growth of Banking & Financial Services Sector.

WhiteOak Capital Pharma & Healthcare Fund will invest a minimum of 80% of its net assets in equity and equity related instruments of Pharma & Healthcare companies. Further, in order to achieve a diversification in the Scheme will invest up to 20% of its net assets in companies other than those engaged in Pharma & Healthcare Sector.

The Scheme will be actively managed and will follow a bottom-up approach to stock-picking and choose companies which are expected to get benefitted from the growth in the Pharma and Healthcare space.

Both the schemes will use a in-house proprietary valuation approach that has been trademarked as OpcoFinco.

WhiteOak Capital Banking & Financial Services Fund’s performance will be benchmarked against Nifty Financial Services Total Return Index.

And WhiteOak Capital Pharma & Healthcare Fund’s performance will be benchmarked against S&P BSE Healthcare TRI.

The WhiteOak Capital Banking & Financial Services Fund will be managed by Ms. Trupti Agrawal (For Equity Securities), Mr. Piyush Baranwal (For Debt Securities), Mr. Ramesh Mantri (For Equity Securities) and Mr. Shariq Merchant (for overseas investments).

The WhiteOak Capital Pharma & Healthcare Fund will be managed by Mr. Ramesh Mantri (For Equity Securities) and Mr. Dheeresh Pathak, Mr. Piyush Baranwal (For Debt Securities), and Mr. Shariq Merchant (for overseas investments).

Both the NFOs opens for subscription on January 16, 2024 and closes on January 30, 2024. The schemes will reopen for continuous sale and repurchase Within five Business Days from the date of allotment.

The minimum subscription amount is Rs 500/- and in multiples of Re.1/- thereof for both the schemes.

The scheme offers Regular Plan and Direct Plan each plan offers Growth option and Income Distribution cum capital withdrawal Option (IDCW).